Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany. The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics.
View Agenda: http://bit.ly/2BOsODK
The congress will cover 2 areas focusing on:
- Novel Strategies & Technologies for Microbiome Drug Discovery
- Therapeutic Potential of the Microbiome
- New for 2018! Workshop on commercialising microbiome therapeutics.
Further sessions will focus on subjects including bioinformatics, translational modelling, genomic approaches, IP concerns, investment in the microbiome, the gut-brain axis and autoimmune disorders. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.
2018 Microbiome Webinar: Microbiome-Directed Therapeutics to tackle metabolic disorders Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics Register for Free Now: http://bit.ly/2j0IqvO
For more information about our programme and to register for the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk.
